278 related articles for article (PubMed ID: 19551674)
1. A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma.
Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Toto L; Mastropasqua L
Eur J Ophthalmol; 2009; 19(4):594-600. PubMed ID: 19551674
[TBL] [Abstract][Full Text] [Related]
2. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma.
Konstas AG; Holló G; Mikropoulos D; Tsironi S; Haidich AB; Embeslidis T; Georgiadou I; Irkec M; Melamed S
Br J Ophthalmol; 2010 Feb; 94(2):209-13. PubMed ID: 19825835
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
García-López A; Paczka JA; Jiménez-Román J; Hartleben C
BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
Martinez A; Sanchez M
Curr Med Res Opin; 2007 May; 23(5):1025-32. PubMed ID: 17519068
[TBL] [Abstract][Full Text] [Related]
7. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intraocular pressure-lowering effect of every night versus every other night dosing of bimatoprost 0.03%.
Shazly TA; Latina MA
J Ocul Pharmacol Ther; 2011 Aug; 27(4):369-71. PubMed ID: 21663517
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open angle glaucoma eyes: a three-year study.
Gupta V; Srinivasan G; Sharma A; Kapoor KS; Sihota R
J Ocul Pharmacol Ther; 2007 Aug; 23(4):351-8. PubMed ID: 17803433
[TBL] [Abstract][Full Text] [Related]
10. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
Ling Z; Zhang M; Hu Y; Yin Z; Xing Y; Fang A; Ye J; Chen X; Liu D; Wang Y; Sun W; Dong Y; Sun X
Chin Med J (Engl); 2014; 127(5):905-10. PubMed ID: 24571886
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
14. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
Konstas AG; Holló G; Irkec M; Tsironi S; Durukan I; Goldenfeld M; Melamed S
Br J Ophthalmol; 2007 Jun; 91(6):757-60. PubMed ID: 17124241
[TBL] [Abstract][Full Text] [Related]
15. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
[TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC
Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol.
Mesci C; Aydin N; Erbil HH
J Glaucoma; 2011 Oct; 20(8):477-81. PubMed ID: 21048508
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.
Wang K; Xu L; Yuan Z; Yao K; Zhao J; Xu L; Fang A; Zhang M; Wu L; Ji J; Hou J; Liu Q; Sun X
BMC Ophthalmol; 2014 Feb; 14():21. PubMed ID: 24568617
[TBL] [Abstract][Full Text] [Related]
19. The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma.
Stankiewicz A; Wierzbowska J; Siemiatkowska A; Fuksinska B; Robaszkiewicz J; Zegadlo A; Ehrlich R; Siesky B; Harris A
Br J Ophthalmol; 2010 Oct; 94(10):1307-11. PubMed ID: 20558428
[TBL] [Abstract][Full Text] [Related]
20. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
Parrish RK; Palmberg P; Sheu WP;
Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
